In this monthly roundup, the global beauty and personal care supply chain continues to undergo significant transformation as ingredient manufacturers, contract producers and specialist suppliers reassess their operations and investment priorities.
Consolidation remains a major theme across Europe’s chemicals industry. BASF reportedly explored a potential deal involving Evonik, highlighting the pressure facing major chemical producers to reassess their business structures amid challenging market conditions. Although no transaction has been confirmed, the reported discussions reflect wider questions surrounding scale, competitiveness and the future configuration of Europe’s speciality chemicals sector, which supplies essential ingredients to the global cosmetics industry.
Manufacturing pressures are also becoming increasingly visible. INEOS idled its acetyls plants in Hull as high European energy costs continued to affect industrial competitiveness. The decision highlights the challenges facing chemical manufacturers operating in energy-intensive industries and raises broader questions about the resilience of European production capacity. For cosmetics manufacturers, developments further upstream in the chemicals supply chain can have implications for raw material availability, sourcing strategies and long-term cost structures.
Portfolio optimisation is another defining theme. Solabia is refocusing its business on cosmetics and nutraceuticals under newly appointed CEO Muriel Koch, signalling a sharper strategic emphasis on markets where scientific expertise and specialised ingredients can deliver competitive advantage. The move reflects the growing convergence between beauty, nutrition and health as ingredient suppliers position themselves around higher-value applications.
Symrise is also reshaping its portfolio through the divestment of its terpene ingredients business to Mutares. The transaction illustrates how established fragrance and ingredient manufacturers are reassessing non-core activities to concentrate resources on strategic growth areas. As demand for specialised, high-performance ingredients evolves, portfolio discipline is becoming increasingly important across the supply sector.
Innovation partnerships continue to strengthen the connection between global beauty brands and their manufacturing partners. L’Oréal and Cosmax agreed to collaborate on next-generation beauty innovations, bringing together the research capabilities of one of the world’s largest cosmetics groups with the formulation and manufacturing expertise of a leading South Korean ODM. The partnership highlights the increasing importance of collaborative development as brands seek to accelerate innovation and respond to rapidly changing consumer expectations.
Automation is attracting investment as manufacturers look to improve productivity and production capabilities. APS Innovation acquired cosmetics automation equipment manufacturer Irae for KRW24.5 billion, strengthening its position in technologies supporting cosmetics manufacturing. The transaction demonstrates how automation specialists are becoming increasingly important to an industry seeking greater precision, flexibility and efficiency across production processes.
Private equity is also targeting businesses that support the expansion of K-beauty. CVC Capital invested KRW300 billion in Silicon2, a South Korean beauty distributor, highlighting the growing strategic value of distribution infrastructure as Korean cosmetics brands expand internationally. The investment reflects how global beauty growth increasingly depends not only on product innovation, but also on the logistics, market access and distribution capabilities required to reach international consumers.
Contract manufacturing remains another attractive area for investment. River Associates acquired personal care manufacturer Diamond Wipes, demonstrating continued private equity interest in specialist production businesses serving established and emerging consumer brands. As more beauty companies rely on external manufacturing partners, businesses offering scalable production, formulation expertise and reliable supply capabilities are becoming increasingly valuable.
Corporate governance and leadership are evolving alongside these operational changes. dsm-firmenich appointed Richard Ridinger as Chairman of the Board, bringing new leadership to the ingredients group as it continues to navigate a changing global market. The appointment comes at a time when major suppliers are balancing innovation investment with portfolio restructuring and operational efficiency.
Regulatory scrutiny is also influencing the supply landscape. dsm-firmenich agreed to a US$33 million settlement in a fragrance antitrust case, highlighting the legal and financial risks associated with competition compliance in the ingredients industry. The development reinforces the importance of robust governance and commercial practices as global fragrance suppliers operate within increasingly scrutinised markets.
Taken together, this monthly roundup highlights a supply chain undergoing significant structural change. European chemical manufacturers are confronting competitiveness challenges, ingredient suppliers are sharpening their portfolios, and investors are targeting automation, manufacturing and distribution businesses that support future growth. In 2026, supply-side success will increasingly depend on combining scientific innovation with operational resilience, strategic investment and the ability to adapt to a rapidly evolving global beauty market.
